Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allisartan isoproxil versus perindopril in chronic congestive heart failure
ChiCTR1800016350Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of allisartan isoproxil and perindopril in heart failure (HF) (2 arms), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoints: Left ventricular ejection fraction at 12 months, Left ventricular diastolic diameter at 12 months and 9 more. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
allisartan isoproxilperindopril
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR1800016350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016350.